Biotechnology Stocks I Performance Guide: Compare Returns of S&P 500 and Cartesian Therapeutics, Inc. (RNAC)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
Compare Returns for S&P 500 and RNAC | ||
---|---|---|
S&P 500 | RNAC | |
Start Date | Jul-01-2016 | Jul-29-2016 |
Start Price | $2,476.46 | $329.72 |
End Date | May-01-2024 | May-17-2024 |
End Price | $5,018.39 | $26.43 |
Number Monthly Prices | 95 | 95 |
Min Date | Oct-01-2016 | Mar-28-2024 |
Min Price | $2,763.85 | $19.50 |
Max Date | Apr-01-2024 | Oct-31-2017 |
Max Price | $5,243.77 | $636.60 |
Total Return | 80.25% | -91.98% |
Annualized Return | 7.73% | -27.30% |
Current Value of $1,000 Purchase | $1,803 | $80 |
Number Returns | 4,465 | 4,465 |
Average Return | 22.54% | -43.60% |
Minimum Return | -25.54% | -96.94% |
Maximum Return | 89.73% | 207.82% |
Number Profitable Returns | 3,862 | 807 |
Percent Profitable Returns | 86.49% | 18.07% |
Number Unprofitable Returns | 603 | 3,658 |
Percent Unprofitable Returns | 13.51% | 81.93% |
Profitable to Unprofitable Returns Ratio | 6.40 | 0.22 |
RNAC Performance Table and Chart
RNAC Dollar-cost Average
RNAC Trendline Chart
RNAC Moving Average Chart
RNAC Stock Return Map - See Patterns of Gains and Losses
RNAC Stock Returns/Purchase Dates